Taiwan boosting stocks of drug used to treat mycoplasma pneumoniae

Taiwan has ramped up production and imports of the main drug used to treat mycoplasma pneumoniae in children, amid a surge in cases of the respiratory illness reported in China in recent weeks, the Taiwan Food and Drug Administration (TFDA) said Wednesday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)